Can-Fite BioPharma (CANF) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CANF is expected to report earnings to rise 767.00% to -8 cents per share on March 23

Can-Fite BioPharma CANF Stock Earnings Reports

Q4'22

Est.

$-0.09

Q3'22

Beat

by $0.08

Q2'22

Beat

by $0.04

Q1'22

Beat

by $0.14

The last earnings report on November 25 showed earnings per share of 0 cents, beating the estimate of -9 cents. With 12.91K shares outstanding, the current market capitalization sits at 13.37M.

View a ticker or compare two or three

Compare

CANF

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CANF
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

26 Ben Gurion Street

Phone

+972 39241114

Employees

Web

http://www.canfite.com